연구성과로 돌아가기
2024 연구자 정보 (819 / 1079)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kim, Insu (Kim, I) |
Dong A Univ, Coll Med, Dept Internal Med, Busan, South Korea |
|
|
[JCR상위 37.6] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study [JCR상위 79.3] PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC |
SCIE | 37.6 | ONCOLOGY |
fireajh@gmail.com; ejspulm@pusan.ac.kr;fireajh@gmail.com; |
||
|
Kim, Jehun (Kim, J) |
Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea |
|
|
[JCR상위 37.6] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study [JCR상위 79.3] PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC |
SCIE | 37.6 | ONCOLOGY |
fireajh@gmail.com; ejspulm@pusan.ac.kr;fireajh@gmail.com; |
||
|
Kim, Saerom (Kim, S) |
Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea |
|
|
[JCR상위 37.6] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study | SCIE | 37.6 | ONCOLOGY | fireajh@gmail.com; | ||
|
Kim, Soo Min (Kim, SM) |
Hanyang Univ, Inst Hlth & Soc, Seoul, South Korea Natl Food Safety Informat Serv, Off Policy Res, Seoul, South Korea Univ Washington, Sch Med, Dept Urol, Seattle, WA USA |
|
0000-0002-6822-9050 KIM, SOO MIN |
[JCR상위 37.6] Epidemiological Characteristics of HIV-Infected Individuals by the Registration for Special Exempted Calculation: A Nationwide Cohort Study | ESCI | 37.6 | INFECTIOUS DISEASES | ychoi3@fredhutch.org; | ||
|
Kim, Suho (Kim, S) |
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea |
|
|
[JCR상위 37.6] Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma | SCIE | 37.6 | ONCOLOGY | oj-cumc@daum.net;pssung@catholic.ac.kr; | ||
|
Kim, Tae Hoon (Kim, TH) |
Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Chang Won, South Korea Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea |
D-7205-2016 GXF-5826-2022 Kim, Chang-Hoon kim, Tae-hoon |
|
[JCR상위 37.6] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study [JCR상위 79.3] PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC |
SCIE | 37.6 | ONCOLOGY |
fireajh@gmail.com; ejspulm@pusan.ac.kr;fireajh@gmail.com; |
||
|
Kim, Tark (Kim, T) |
Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Div Infect Dis, Bucheon, South Korea Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Divison Infect Dis, Bucheon, South Korea |
LNP-3907-2024 AAG-1822-2019 KIM, TARK Kim, Woo |
|
[JCR상위 37.6] Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID [JCR상위 25.2] Incidence of Clostridioides difficile Infections in Republic of Korea: A Prospective Study With Active Surveillance vs. National Data From Health Insurance Review & Assessment Service |
ESCI SCIE |
25.2 |
INFECTIOUS DISEASES MEDICINE, GENERAL & INTERNAL |
infection@korea.ac.kr; paihj@hanyang.ac.kr; |
||
|
Kim, Woo Joo (Kim, WJ) |
Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis,Guro Hosp, 148 Gurodong Ro, Seoul 08308, South Korea KU Med VIC K, Vaccine Innovat Ctr, Seoul 02841, South Korea |
D-2733-2015 Kim, Woo Joo Kim, Woo |
0000-0002-4546-3880 Kim, Woo Joo |
[JCR상위 37.6] Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition [JCR상위 34.6] Real-world effectiveness of influenza vaccine over a decade during the 2011-2021 seasons-Implications of vaccine mismatch |
ESCI SCIE |
34.6 |
INFECTIOUS DISEASES IMMUNOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL |
heejinmd@korea.ac.kr; wjkim@korea.ac.kr; |
||
|
Kim, Youn Jeong (Kim, YJ) |
Catholic Univ Korea, Incheon St Marys Hosp, Dept Internal Med, Div Infect Dis,Coll Med, Incheon, South Korea Catholic Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Internal Med, Incheon 21431, South Korea |
|
|
[JCR상위 37.6] Epidemiological Characteristics of HIV-Infected Individuals by the Registration for Special Exempted Calculation: A Nationwide Cohort Study [JCR상위 13.5] Health screening disparities in people living with HIV; A nationwide organized screening setting [JCR상위 32.5] Association between obesity and cancer risk in adults with HIV in Korea |
ESCI SCIE |
13.5 |
INFECTIOUS DISEASES INFECTIOUS DISEASES;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH IMMUNOLOGY;INFECTIOUS DISEASES;VIROLOGY |
ychoi3@fredhutch.org; hayejine@hanyang.ac.kr; hayejine@hanmail.net; |
||
|
Korean Soc Infect Dis (Korean Soc Infect Dis) |
|
|
[JCR상위 37.6] COVID-19 Vaccination Recommendations for 2024-2025 in Korea | ESCI | 37.6 | INFECTIOUS DISEASES | wbpark1@snu.ac.kr; | |||
|
Kristensen, Mathilde K. (Kristensen, MK) |
Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu, South Korea Aarhus Univ, Fac Hlth, Med, Aarhus, Denmark |
|
|
[JCR상위 37.6] TAZ is involved in breast cancer cell migration via regulating actin dynamics | SCIE | 37.6 | ONCOLOGY | thkwon@knu.ac.kr; | ||
|
Kwon, Tae-Hwan (Kwon, TH) |
교신저자 |
Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu, South Korea Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, KNU Convergence Educ Program BK21 4, Taegu, South Korea Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, 680 Gukchaebosang Ro, Daegu 41944, South Korea Kyungpook Natl Univ, Sch Med, Daegu, South Korea Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, BK21 FOUR KNU Convergence Educ Program, Taegu, South Korea Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, BK21 KNU Convergence Educ Program 4, Taegu, South Korea |
ABA-1981-2020 Kwon, Tae-Hwan |
0000-0002-1561-6508 Kwon, Tae-Hwan |
[JCR상위 37.6] TAZ is involved in breast cancer cell migration via regulating actin dynamics [JCR상위 15.4] Does the primary cilium elongation play a role in urine concentration? [JCR상위 4.1] The TRIM28-PARP1-CTNNB1 Complex Is Associated with the Transcriptional Elongation Machinery for Aqp2 Gene Transcription [JCR상위 18.4] Poly(ADP-ribose) polymerase-1 affects vasopressin-mediated AQP2 expression in collecting duct cells of the kidney (vol 326, pg F69, 2024) [JCR상위 18.4] Poly(ADP-ribose) polymerase-1 affects vasopressin-mediated AQP2 expression in collecting duct cells of the kidney |
SCIE | 4.1 |
ONCOLOGY UROLOGY & NEPHROLOGY PHYSIOLOGY;UROLOGY & NEPHROLOGY |
thkwon@knu.ac.kr; hjung24@jhmi.edu;thkwon@knu.ac.kr; |
|
|
Kwon, Yong Shik (Kwon, YS) |
Keimyung Univ, Sch Med, Dept Internal Med, Busan, South Korea |
|
|
[JCR상위 37.6] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study [JCR상위 79.3] PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC |
SCIE | 37.6 | ONCOLOGY |
fireajh@gmail.com; ejspulm@pusan.ac.kr;fireajh@gmail.com; |
||
|
Lee, Dong-Gun (Lee, DG) |
Catholic Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea |
IWD-9833-2023 Lee, Dong-Gun |
|
[JCR상위 37.6] Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition | ESCI | 37.6 | INFECTIOUS DISEASES | heejinmd@korea.ac.kr; | ||
|
Lee, Eunjung (Lee, E) |
Soonchunhyang Univ, Seoul Hosp, Dept Internal Med, Div Infect Dis,Coll Med, Seoul, South Korea |
|
0000-0002-7724-8288 Lee, Eunjung |
[JCR상위 37.6] Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID | ESCI | 37.6 | INFECTIOUS DISEASES | infection@korea.ac.kr; |
페이지 이동: